FR2118117B1 - - Google Patents

Info

Publication number
FR2118117B1
FR2118117B1 FR7145225A FR7145225A FR2118117B1 FR 2118117 B1 FR2118117 B1 FR 2118117B1 FR 7145225 A FR7145225 A FR 7145225A FR 7145225 A FR7145225 A FR 7145225A FR 2118117 B1 FR2118117 B1 FR 2118117B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7145225A
Other languages
French (fr)
Other versions
FR2118117A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB6006470A external-priority patent/GB1380246A/en
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of FR2118117A1 publication Critical patent/FR2118117A1/fr
Application granted granted Critical
Publication of FR2118117B1 publication Critical patent/FR2118117B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
FR7145225A 1970-12-17 1971-12-16 Expired FR2118117B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6006470A GB1380246A (en) 1970-12-17 1970-12-17 3alpha-hydroxy-androstanes and esters thereof

Publications (2)

Publication Number Publication Date
FR2118117A1 FR2118117A1 (en) 1972-07-28
FR2118117B1 true FR2118117B1 (en) 1975-12-26

Family

ID=10484935

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7145225A Expired FR2118117B1 (en) 1970-12-17 1971-12-16

Country Status (9)

Country Link
AU (1) AU473167B2 (en)
BE (1) BE776786A (en)
CA (1) CA988508A (en)
CH (1) CH616691A5 (en)
DE (1) DE2162555A1 (en)
DK (1) DK133682B (en)
FR (1) FR2118117B1 (en)
IL (1) IL38376A (en)
ZA (1) ZA718466B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1434919A (en) * 1972-06-15 1976-05-12 Glaxo Lab Ltd 3alpha-hydroxy androstanes
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
DE69435286D1 (en) 1993-05-24 2010-05-20 Purdue Pharma Ltd METHOD AND COMPOSITIONS FOR EFFECTING SLEEP
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (en) * 1942-04-25 1951-02-28 Nv Organon Process for the preparation of a compound of the cyclopentanopolyhydrophenanthrene series which contains an oxygen-containing group in ring C.
US2824871A (en) * 1951-11-29 1958-02-25 Upjohn Co Steroid compounds and process
FR1281205A (en) * 1956-12-21 1962-01-12 Organon Nv Process for obtaining compounds of the pregnane series

Also Published As

Publication number Publication date
IL38376A (en) 1977-07-31
FR2118117A1 (en) 1972-07-28
DK133682C (en) 1976-12-20
DE2162555A1 (en) 1972-06-22
CA988508A (en) 1976-05-04
CH616691A5 (en) 1980-04-15
AU473167B2 (en) 1976-06-17
ZA718466B (en) 1973-08-29
AU3696271A (en) 1973-06-21
DK133682B (en) 1976-06-28
BE776786A (en) 1972-06-16
IL38376A0 (en) 1972-02-29

Similar Documents

Publication Publication Date Title
FR2118123B1 (en)
DK133682C (en)
AU2044470A (en)
AU1473870A (en)
AU1336970A (en)
AU2130570A (en)
AU2085370A (en)
AU2017870A (en)
AU1833270A (en)
AU1832970A (en)
AU1918570A (en)
AU1841070A (en)
AU1872870A (en)
AU1879170A (en)
AU1343870A (en)
AU1881070A (en)
AU1969370A (en)
AU1974970A (en)
AU1943370A (en)
AU1328670A (en)
AU2061170A (en)
AU1789870A (en)
AU2112570A (en)
AU2115870A (en)
AU2324170A (en)

Legal Events

Date Code Title Description
ST Notification of lapse